Our story
- About us
- Latest
- Centres
Our science
- Mission
  - Discover
  - Develop
  - Deliver
- Approaches
- Explore by
Our people
- Researchers
- Governance
- Latest
  
  Feb 19, 2026
  
  First Group Leaders announced for new dedicated Parkinson's Research Centre
  
  In 2025, the UK DRI partnered with Parkinson’s UK to launch a new £10m research...
  Learn more First Group Leaders announced for new dedicated Parkinson's Research Centre
Our partners
- Partnerships
- Initiatives
- Latest
  
  Jan 01, 2024
  
  Why partner with the UK DRI?
  
  The UK DRI is central to a rich and connected dementia research ecosystem, and we...
  Learn more Why partner with the UK DRI?
Careers
- Join us
  - Vacancies
  - Centres
- Latest
  
  Jan 01, 2024
  
  Why join the UK DRI?
  
  By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists...
  Learn more Why join the UK DRI?
Public Information
- Information
- Dementias
- Movement conditions

Prof Karen Horsburgh

Personal Chair of Neuroscience, University of Edinburgh Centre for Discovery Brain Sciences

News

Feb 05, 2025 - Q&A

Project launched to identify new drug target for vascular dementia

Vascular dementia is one of the most common types of dementia and is growing in...

Learn more Project launched to identify new drug target for vascular dementia

Key publications

Glia

Published Jul 19, 2017

Minocycline reduces microgliosis and improves subcortical white matter function in a model of cerebral vascular disease.

Authors

Yasmina Manso, Philip R Holland, Akihiro Kitamura, Stefan Szymkowiak, Jessica Duncombe, Edel Hennessy, James L Searcy, Martina Marangoni, Andrew D Randall, Jon T Brown, Barry W McColl, Karen Horsburgh

Minocycline reduces microgliosis and improves subcortical white matter function in a model of cerebral vascular disease.